ArticleThe Journal of clinical investigation2023

Ruxolitinib improves hematopoietic regeneration by restoring mesenchymal stromal cell function in acute graft-versus-host disease.

Yan Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.